Listed

Pfizer Inc: Form 10-Q for the period ended Apr 3, 2022

Filed with the SEC on May 11, 2022 and accepted by EDGAR at May 11, 2022, 16:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-04-03. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-01-01 to 2022-04-03$25.66bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-01-01 to 2022-04-03$9.98bnus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2022-01-01 to 2022-04-03$2.59bnus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense3 months2022-01-01 to 2022-04-03$322.0mus-gaap:InterestExpense
Income tax3 months2022-01-01 to 2022-04-03$1.17bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-01-01 to 2022-04-03$7.86bnus-gaap:NetIncomeLoss
Diluted EPS3 months2022-01-01 to 2022-04-03$1.37us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-01-01 to 2022-04-03$1.40us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-01-01 to 2022-04-035,758,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2022-01-01 to 2022-04-03$6.54bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-01-01 to 2022-04-03$643.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases3 months2022-01-01 to 2022-04-03$2.00bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2022-04-03$2.47bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-04-03$54.42bnus-gaap:AssetsCurrent
Total assetsAt period end2022-04-03$183.84bnus-gaap:Assets
Current liabilitiesAt period end2022-04-03$39.27bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-04-03$101.16bnus-gaap:Liabilities
Long-term debtAt period end2022-04-03$35.66bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2022-04-03$260.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2022-04-03$82.42bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000078003-22-000071. Last ingested by Listed: Nov 12, 2026, 18:08 ET. Listed shows no prices and gives no investment advice.